Production, development drive automation buys

Production management software and analytics software are two of the fastest growing automation technologies being deployed by pharmaceutical manufacturers. 

"Much of the current automation focuses on projects with immediate return on investments, projects that are the result of consolidation of manufacturing operations, and standardization of applications across the entire enterprise," says John Blanchard, principal analyst at ARC, in an announcement. Blanchard has authored a report, Automation Expenditures for Pharmaceutical and Biotech Industry Worldwide Outlook.

For some suppliers, he notes, analytics help reduce production cycle time and throughput. For others, analytics help evaluate solvent extraction schemes, reducing the number of experiments performed during drug development. 

"Even with tightening budgets and the current financial crisis, the market for automation products and systems in the pharmaceutical and biotech industry continues to be moderate to strong," Blanchard says.  He projects pharma/biotech automation expenditures to exceed $3 billion by 2012. 

- here's the announcement

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.